DeepMind Launches AlphaGenome 2 to Trace Disease Roots in DNA
Google DeepMind has introduced AlphaGenome 2, a model that predicts how DNA affects human cells. It finds almost twice as many significant variants as the previous version.
Google DeepMind introduced AlphaGenome 2, a model that predicts how changes in DNA affect the behavior of specific human cell types. Google DeepMind is the company's AI research lab. The model was trained on profiles of more than 107 million individual cells across 68 tissues. According to the developers, it identifies nearly twice as many DNA variants that alter gene expression, the process by which genes turn on or off, compared with the earlier AlphaGenome model.
The point is to trace diseases to the exact cell type involved, rather than to an averaged tissue, which was the limit of the earlier version. In tests on inflammatory bowel disease and on the immune response to COVID-19, the model reproduced disease mechanisms already known from lab studies. AlphaGenome 2 is available now for non-commercial research. For commercial use, it remains in a private preview, not yet open to the public.
Source: deepmind.google
Free course
Stop reading about AI — start building with it
The free Claude Code course: your first site, tool or game — no coding. No upsells, no cross-sells — nothing to buy here.
Start free →
Author
Evgenii Arsentev
PhD · Founder & CEO, Dad4Kids
Articles · Latest articles